自动RADP:一个可解释的深度学习框架,用电子健康记录来预测阿尔茨海默病和相关痴呆症的快速进展
medRxiv : the preprint server for health sciences
|April 29, 2025
概括
本研究介绍了AutoRADP,这是一个AI框架,使用电子健康记录预测阿尔茨海默病 (AD) 和相关痴呆症 (ADRD) 的快速进展. AutoRADP为更好的临床决策和个性化的患者护理提供了准确,可解释的见解.
科学领域:
- 人工智能在医学中的应用
- 神经退行性疾病研究研究
- 生物医学信息学 生物医学信息学
背景情况:
- 阿尔茨海默病 (AD) 和与AD相关的痴呆症 (ADRD) 呈现出不同的进展率,使早期干预复杂化.
- 电子健康记录 (EHR) 为开发疾病轨迹的预测模型提供了丰富的数据.
研究的目的:
- 开发一个可解释的机器学习框架,AutoRADP,用于预测AD/ADRD的快速进展.
- 利用结构化和非结构化EHR数据来提高预测准确度.
主要方法:
- 利用基于自动编码器的框架 (AutoRADP) 结合基于规则的NLP来从临床笔记中进行认知评估.
- 采用特征选择和混合抽样策略来解决数据不平衡.
- 综合的夏普利添加式解释 (SHAP) 用于模型的解释性.
主要成果:
- 与现有方法相比,AutoRADP在预测AD/ADRD快速进展方面表现优越.
- 通过可解释的SHAP值,确定了促进疾病快速进展的关键因素.
- 从非结构化的临床笔记中成功提取了关键的认知数据.
结论:
- 通过能够准确和可解释地预测AD/ADRD的快速进展,AutoRADP促进了精准医学的发展.
- 该框架支持改善临床决策,并为AD/ADRD患者提供个性化干预.
相关概念视频
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128


